Tricornered/NDR kinase signaling mediates PINK1-directed mitochondrial quality control and tissue maintenance

  1. Bingwei Lu1,7
  1. 1Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA;
  2. 2Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan;
  3. 3CREST (Core Research for Evolutionary Science and Technology), Japan Science and Technology Agency, Saitama 332-0012, Japan;
  4. 4Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan;
  5. 5Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan;
  6. 6Department of Neuroscience for Neurodegenerative Disorders, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan

    Abstract

    Eukaryotes employ elaborate mitochondrial quality control (MQC) to maintain the function of the power-generating organelle. Parkinson's disease-associated PINK1 and Parkin actively participate in MQC. However, the signaling events involved are largely unknown. Here we show that mechanistic target of rapamycin 2 (mTORC2) and Tricornered (Trc) kinases act downstream from PINK1 to regulate MQC. Trc is phosphorylated in mTORC2-dependent and mTORC2-independent manners and is specifically localized to mitochondria in response to PINK1, which regulates mTORC2 through mitochondrial complex-I activity. Genetically, mTORC2 and Trc act upstream of Parkin. Thus, multiplex kinase signaling is acting between PINK1 and Parkin to regulate MQC, a process highly conserved in mammals.

    Keywords

    Footnotes

    • Received August 13, 2012.
    • Accepted December 4, 2012.
    | Table of Contents

    Life Science Alliance